These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 13702952)

  • 41. Vaccines for preventing typhoid fever.
    Anwar E; Goldberg E; Fraser A; Acosta CJ; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2014 Jan; (1):CD001261. PubMed ID: 24385413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [COMPARATIVE STUDIES ON THE RESISTANCE OF MICE IMMUNIZED WITH TYPHOID O AND VI VACCINES TO THE INFECTION].
    LVOVSKAIA NV
    Biull Eksp Biol Med; 1965 Feb; 59():95-7. PubMed ID: 14273504
    [No Abstract]   [Full Text] [Related]  

  • 43. Assay of typhoid vaccines with Salmonella typhosa-Salmonella typhimurium hybrids.
    Diena BB; Johnson EM; Baron LS; Wallace R; Greenberg L
    Infect Immun; 1973 Jan; 7(1):5-8. PubMed ID: 4120357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adhesion of Vi antigen and toxicity in typhoid vaccines inactivated by acetone or by heat and phenol.
    Wong KH; Feeley JC; Pittman M; Forlines ME
    J Infect Dis; 1974 May; 129(5):501-6. PubMed ID: 4207306
    [No Abstract]   [Full Text] [Related]  

  • 45. Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines.
    Zuckerman JN; Hatz C; Kantele A
    Expert Rev Vaccines; 2017 Oct; 16(10):1029-1043. PubMed ID: 28856924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CHARACTERIZATION OF HUMAN ANTIBODIES TO SALMONELLA TYPHI BY GEL-FILTRATION AND ANTIGENIC ANALYSIS.
    TURNER MW; ROWE DS
    Immunology; 1964 Nov; 7(6):639-56. PubMed ID: 14239839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Immunity against typhoid fever. I. Wright's anti-typhoid vaccination, 1896 to 1979].
    Milhomem AM; Suassuna I
    Mem Inst Oswaldo Cruz; 1982; 77(1):93-120. PubMed ID: 6755159
    [No Abstract]   [Full Text] [Related]  

  • 48. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [EFFECT OF PREVIOUSLY INJECTED DYSENTERIAL AND STAPHYLOCOCCAL VACCINES ON THE IMMUNITY TO TYPHOID BACTERIA IN IRRADIATED ANIMALS].
    DUPLISHCHEVA AP; CHAKHAVA OV
    Radiobiologiia; 1964; 4():419-23. PubMed ID: 14189213
    [No Abstract]   [Full Text] [Related]  

  • 50. [General immune reactions in man following oral administration of acetone-inactivated typhoid vaccines. II].
    Karolcek J; Draskovicová M; Greorch D; Mikulková V; Luzová D
    Zentralbl Bakteriol Orig; 1969; 211(4):502-10. PubMed ID: 4916992
    [No Abstract]   [Full Text] [Related]  

  • 51. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH; Kantele JM; Kantele A
    Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. EVALUATION OF TYPHOID VACCINES IN THE LABORATORY AND IN A CONTROLLED FIELD TRIAL IN POLAND. PRELIMINARY REPORT.
    BLAKE JB
    Bull World Health Organ; 1965; 32(1):15-27. PubMed ID: 14290075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Salmonella typhi Vi antigen-negative isolates in India and prophylactic typhoid immunization.
    Arya SC
    Natl Med J India; 2000; 13(4):220. PubMed ID: 11002694
    [No Abstract]   [Full Text] [Related]  

  • 54. SEROLOGICAL RESPONSES OF MAN TO TYPHOID VACCINES.
    BENENSON AS
    Bull World Health Organ; 1964; 30(5):653-62. PubMed ID: 14196813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Stimulation of lymphocyte cultures using typhoid O-antigen].
    Renner HH; Stärk J; Mauler R
    Klin Wochenschr; 1969 Apr; 47(8):431-3. PubMed ID: 5383654
    [No Abstract]   [Full Text] [Related]  

  • 56. [ON ENTERAL IMMUNIZATION AGAINST TYPHOID. I. EFFECTIVENESS OF ENTERAL IMMUNIZATION AGAINST TYPHOID WITH ESCHERICHIA COLI CONTAINING VI-ANTIGEN].
    PERSHIN BB
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Aug; 40():19-23. PubMed ID: 14091792
    [No Abstract]   [Full Text] [Related]  

  • 57. [The specific resistance produced by typhoid-paratyphoid vaccination compared with the immunity status of former typhoid fever patients as a criterion of evaluation of the effectiveness of T.A.B. vaccine].
    NESTORESCO N
    Arch Roum Pathol Exp Microbiol; 1961 Sep; 20():321-35. PubMed ID: 14479101
    [No Abstract]   [Full Text] [Related]  

  • 58. [Is the Widal reaction for typhoid and paratyphoid influenced by the oral intake of larger amounts of killed Salmonella?].
    Finger H; Seeliger H; Schmidt H
    Dtsch Med Wochenschr; 1967 May; 92(19):887-90. PubMed ID: 4960680
    [No Abstract]   [Full Text] [Related]  

  • 59. A contribution to the laboratory assay of typhoid vaccines.
    RASKA K; MATEJOVSKA D; JELINEK J
    Bull World Health Organ; 1962; 26(3):381-8. PubMed ID: 14490443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A SUGGESTION FOR A NEW ANTITYPHOID VACCINE.
    ANDERSON ES; GUNNELL A
    Lancet; 1964 Dec; 2(7371):1196-200. PubMed ID: 14215557
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.